Bath
Bath
Bath, Somerset, United Kingdom13 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004) | Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Phase 2 | 2026-10-08 | NCT07033494 | |
| A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013) | Radiographic Axial Spondyloarthritis | Recruiting | Phase 2 | 2026-09-28 | NCT07133633 | |
| A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02) | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 3 | 2026-09-24 | NCT06018337 | |
| Dietary Fibres on Gut Fermentation | Healthy Adult | Recruiting | Not applicable | 2026-09-23 | NCT07837297 | |
| A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes | Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitus | Recruiting | Phase 3 | 2026-09-14 | NCT07088068 | |
| Resistance Exercise, IL-7 and Immune Phenotypes in Prostate Cancer | Atrophy, Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, muscular atrophy, neoplasm, nervous system disorder, prostate cancer, prostate disorder | Not yet recruiting | Not applicable | 2026-07-23 | NCT07724080 | |
| SEquential Treatment of PSoriasis With Biologics | Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, psoriasis, skin disorder | Recruiting | Not stated | 2026-07-09 | NCT07187817 | |
| Evaluation Of Outcomes Following Rotator Cuff Repair Using the REGENETEN Bioinductive Implant | Rotator Cuff Injuries, Rupture, Shoulder Injuries, Tendon Injuries, injury | Recruiting | Not stated | 2026-06-01 | NCT06857084 | |
| A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05) | HER2-Positive Primary Breast Cancer; Residual Invasive Breast Cancer | Active, not recruiting | Phase 3 | 2026-05-15 | NCT04622319 | |
| Can Personalised Digital Feedback Help Increase Plant Food Intake? | Plant Food Intake | Recruiting | Not applicable | 2026-03-17 | NCT07478068 | |
| Focused Orticumab Research for Treating Inflammation in Coronary Arteries | Infarction, Inflammation, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute coronary syndrome, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder | Recruiting | Phase 2 | 2026-01-27 | NCT06927739 | |
| Treatment Effectiveness in People With axSpA or PsA Starting Treatment With Bimekizumab, Risankizumab, Guselkumab, Upadacitinib, or a TNF Inhibitor | Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, Spondylarthritis, Spondylarthropathies, arthritic joint disease, arthropathy, bone disorder, musculoskeletal system disorder, psoriasis, psoriatic arthritis, skin disorder, spondylitis, vertebral column disorder | Recruiting | Not stated | 2025-09-10 | NCT07166315 | |
| Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Phase 2 / Phase 3 | 2023-04-18 | NCT00268476 |